Lion TCR

Two new venture capital funds were announced a day apart during the last week of June, each with $200m to fund early-stage biotechnology companies, though only one is exclusively focused on drug devel

Pfizer Inc. 's commitment of an additional $600m to its corporate venture capital fund includes a plan to spend 25% on neuroscience investments – a curious move considering the company's decision at t

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biophar